Remember this while the naysayers speak about where the
Remember this while the naysayers speak about where the share price is:
1. Share Price means nothing at this point since company will not be diluting through the use of shares to the public market during this time period. This is a pre-revenue OTC and things can and will change VERY quickly. This is either win or lose by September 30th and management knows this.
2. We are obviously in a hold position and volume indicates that Aspire is NOT selling in droves, if at all.
3. Bad news on Prurisol would have to be disseminated immediately to shareholders!
4. Good news in regards to Prurisol and BTD for B-OM can and WILL be held until management deems right to disseminate (unless the information is leaked)
5. The longer we sit quiet the more and more and more you should feel excited about the news to come (if you are long).
6. News is scheduled on or before 9/30/18, the same time IPIX will need to file their 10K annual financial report which may disclose a WHOLE LOT.
Better to not engage with the obvious FUDsters. Hold tight. Buy the dips. Do your own DD. Science, Science, Science.
IMO we get all news in one shot around the 3rd week in September:
Best Case- Prurisol great, BTD affirmed, Buyout agreed by certain date for certain price.
Next Case- Prurisol median, BTD affirmed, partnership for B franchise
Next one down- Prurisol needs to be reformulated for already shown efficacy end points (itching, swelling), BTD not granted or not (yet), B-OM partnership announcement.
Worst Case- None of this occurs and further dilution to go on. (The further we move along without bad news on Prurisol, the less likely this will occur)
HEY WE HAVE 38 BUSINESS DAYS LEFT TO LISTEN TO THE NONSENSE ON THIS BOARD. TIME IS A GETTIN REAL SHORT AROUND HERE. BETTER START FINDING ANOTHER OTC STOCK TO TRY YOUR GARBAGE WITH...
8
1
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Understanding the Investor Landscape The landscape of investor rights is evolving, and in the case of iLearningEngines, Inc., investors find themselves at a significant crossroads. The company, which trades on NASDAQ under the ticker AILE, is currently facing a class action lawsuit led by a dedicated group of investors and the Schall Law Firm. The Class Action Against...
Continue Reading
EditForce's Groundbreaking Research on Myotonic Dystrophy EditForce, Inc. has announced a pivotal breakthrough in the treatment of Myotonic Dystrophy Type 1, significantly enhancing the future of therapeutic options for this challenging condition. The research highlights the efficacy of their innovative PPR platform technology, specifically the CUG-PPR1 protein that...
Continue Reading
The Return of dancemoon MoonRoller and New Layer Brush Mini dancemoon, a pioneer in innovative home cleaning solutions, has officially re-launched its popular flagship product, the dancemoon MoonRoller, alongside the new Layer Brush Mini. This latest offering is now available for purchase globally through the brand's official website and other major e-commerce platforms....
Continue Reading
Carriage Services Announces Earnings Release for Q3 2024 HOUSTON, Carriage Services, Inc. (NYSE: CSV) is set to unveil its third quarter earnings results for 2024. The earnings report is scheduled for release on Wednesday, following the market's closing bell, signaling a vital moment for shareholders and the market at large. Investors are keenly awaiting the insights that...
Continue Reading
Spanish Market Overview The Spanish stock market showed positive momentum recently, with the IBEX 35 index recording a modest gain of 0.19%. This uptick reflects a notable shift in investor sentiment across various sectors, leading to an overall increase in share prices. Leading Sectors Driving Growth The rise in the IBEX 35 was attributed primarily to strong performances...
Continue Reading